Polaryx Therapeutics, Inc. PLYX
1.95 USD +0.08 (+4.28%)
At closeNov 11, 2026, 4:00 PM EST
1.94 -0.01 -0.51%
After hours · Nov 11, 4:00 PM ET
1.90 Day range 1.95
1.69 52-week range 48.91
- YTD
- -94.43%
- 1 year
- -94.43%
- Market cap
- 92.32M
- EPS (ttm)
- -0.14
- YTD return
- -94.43%
- 1-year return
- -94.43%
- Volume
- 7.13K
- Avg volume
- 51.38K
- Open
- 1.90
- Previous close
- 1.87
- Day's range
- 1.90 – 1.95
- 52-week range
- 1.69 – 48.91
5D +0.20 (+11.43%)
Financials — quick view
PLYX Revenue — quarterly 0
PLYX Net income — quarterly -1.38M
PLYX EPS — quarterly -0.03
News
Polaryx Therapeutics Announces Activation Of First Clinical Trial Site For SOTERIA For Eligible Pediatric Participants 
Polaryx Therapeutics Activates First Clinical Trial Site for SOTERIA Phase 2 Basket Trial of PLX-200 
Why Webuy Global Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket 
Polaryx Therapeutics Appoints Dr. Will Charlton as Chief Medical Officer 
Polaryx Therapeutics Advances Operational Readiness for SOTERIA Phase 2 Basket Trial 
This Vail Resorts Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Thursday 
Raymond James Initiates Coverage On Polaryx Therapeutics with Strong Buy Rating, Announces Price Target of $6 
12 Health Care Stocks Moving In Friday's Pre-Market Session - LUCID CAPITAL MARKETS Initiates Coverage On Polaryx Therapeutics with Buy Rating, Announces Price Target of $7
- HC Wainwright & Co. Initiates Coverage On Polaryx Therapeutics with Buy Rating, Announces Price Target of $7
Your note
Sign in to keep a note on PLYX — it syncs with the Stock Master app.